Long-term Outcomes of Anti-viral Therapies in Patients With Chronic Viral Hepatitis B

RecruitingOBSERVATIONAL
Enrollment

33,000

Participants

Timeline

Start Date

September 9, 2020

Primary Completion Date

November 1, 2026

Study Completion Date

December 31, 2031

Conditions
Chronic Hepatitis b
Interventions
DRUG

peginterferon alpha based regimen

peginterferon alpha based regimen or nucleos(t)ide alone are decided by patients' doctors according to their conditions, instead of extra interventions brought by the study

DRUG

nucleos(t)ide

peginterferon alpha based regimen or nucleos(t)ide alone are decided by patients' doctors according to their conditions, instead of extra interventions brought by the study

Trial Locations (1)

200040

RECRUITING

Huashan Hospital, Shanghai

All Listed Sponsors
collaborator

Chinese Foundation for Hepatitis Prevention and Control

UNKNOWN

collaborator

The Third People's Hospital of Taiyuan

OTHER

collaborator

First Affiliated Hospital of Chongqing Medical University

OTHER

collaborator

Beijing YouAn Hospital

OTHER

collaborator

Henan Provincial People's Hospital

OTHER

collaborator

Yunnan Provincial No.1 Hospital

UNKNOWN

collaborator

Third Affiliated Hospital, Sun Yat-Sen University

OTHER

collaborator

The First Affiliated Hospital of Anhui Medical University

OTHER

collaborator

The First Affiliated Hospital of Xiamen University

OTHER

collaborator

Beijing Ditan Hospital

OTHER

collaborator

Tianjing No.2 People's Hospital

UNKNOWN

collaborator

Qingdao No.6 People's Hospital

UNKNOWN

collaborator

The Fourth Affiliated Hospital of Zhejiang University School of Medicine

OTHER

collaborator

Ningbo Beilun District Traditional Chinese Medicine Hospital

OTHER

collaborator

Wuxi No.5 People's Hospital

UNKNOWN

collaborator

Taicang No.1 People's hospital

UNKNOWN

collaborator

First Affiliated Hospital Xi'an Jiaotong University

OTHER

lead

Huashan Hospital

OTHER